000 | 01832 a2200589 4500 | ||
---|---|---|---|
005 | 20250513123538.0 | ||
264 | 0 | _c19970918 | |
008 | 199709s 0 0 eng d | ||
022 | _a0094-6176 | ||
024 | 7 |
_a10.1055/s-2007-996099 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMingers, A M | |
245 | 0 | 0 |
_aHomozygous type I plasminogen deficiency. _h[electronic resource] |
260 |
_bSeminars in thrombosis and hemostasis _c1997 |
||
300 |
_a259-69 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlbumins _xpharmacology |
650 | 0 | 4 |
_aAntigens _xblood |
650 | 0 | 4 |
_aAntithrombin III _xanalysis |
650 | 0 | 4 |
_aBlood Coagulation Disorders _xblood |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aConjunctivitis _xblood |
650 | 0 | 4 |
_aFactor XII _xanalysis |
650 | 0 | 4 |
_aFactor XII Deficiency _xblood |
650 | 0 | 4 | _aFamily Health |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
650 | 0 | 4 |
_aFibrinogen _xanalysis |
650 | 0 | 4 |
_aFibrinolysin _xanalysis |
650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
650 | 0 | 4 |
_aHemostasis _xdrug effects |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMucous Membrane _xpathology |
650 | 0 | 4 |
_aPlasma _xphysiology |
650 | 0 | 4 |
_aPlasminogen _xanalysis |
650 | 0 | 4 |
_aPrekallikrein _xanalysis |
650 | 0 | 4 |
_aProthrombin _xanalysis |
650 | 0 | 4 |
_aalpha-2-Antiplasmin _xanalysis |
700 | 1 | _aHeimburger, N | |
700 | 1 | _aZeitler, P | |
700 | 1 | _aKreth, H W | |
700 | 1 | _aSchuster, V | |
773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 23 _gno. 3 _gp. 259-69 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2007-996099 _zAvailable from publisher's website |
999 |
_c9235585 _d9235585 |